HOME >> BIOLOGY >> NEWS
Major advance in the treatment of severe malaria in our region

A drug derived from an ancient Chinese herb has been shown to reduce the risk of death from severe malaria by a third, potentially saving hundreds of thousands of lives in nations on our doorstep.

A trial in malaria patients from four countries has shown a clear benefit over standard treatment with quinine, says Professor Nicholas Anstey of the Menzies School of Health Research in Darwin, Australia, which participated in the trial in partnership with the Indonesian Ministry of Health.

The regional collaboration between the Indonesian Ministry of Health and Darwin's Menzies School of Health Research has a joint research facility in Timika in Papua province, eastern Indonesia. Hospitals in Bangladesh, Myanmar (Burma), and India also participated in the study, which was coordinated by the Wellcome Trust Unit in Bangkok, Thailand.

The results of the trial are reported in the latest edition of the international medical journal, Lancet, which is published today.

Quinine has been the standard drug for the treatment of severe malaria in most countries, Professor Anstey said. This new trial clearly shows that artesunate, derived from sweet wormwood, or Artemisia annua, has fewer side effects and is more effective than quinine in preventing death in adults with severe malaria.

In total, 1461 patients with severe malaria were treated with either quinine or artesunate. Of these, 20% were enrolled at the Indonesian Ministry of Health/Menzies field site in Papua province.

There were a third fewer deaths among those receiving artesunate: 15% of seriously ill patients died compared to 22% of those treated with quinine.

"Falciparum malaria, the most severe form of the infection, is a major cause of death in our region. At least 120 million cases of falciparum malaria occur in South East Asia each year," Professor Anstey said.

"The reduction in mortality from severe malaria associated with artesunate therapy is excell
'"/>

Contact: Alison Ellis
Alison.Ellis@menzies.edu.au
61-889-228-989
Research Australia
26-Aug-2005


Page: 1 2

Related biology news :

1. Major breakthrough in understanding how HIV interferes with infected cell division
2. Major study predicts grim future for Europes seas
3. Major genetic study identifies clearest link yet to obesity risk
4. Major gene study uncovers secrets of leukemia
5. Major society publisher announces support for public access to scientific literature
6. Major link in brain-obesity puzzle found
7. Major Wellcome Trust award to take science from the bench to the bedside
8. Major breakthrough in the mechanism of myelin formation
9. Major new osteoporosis study to recruit people in Orkney
10. Major genetic risk factor found for prostate cancer
11. Major report on tigers to be released Thursday at National Zoo

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2019)... ... June 19, 2019 , ... The half-million dollars ... of America Foundation, and the possibly millions of dollars of “high priority” grants ... AD, are a “welcome affirmation” of the need to investigate more thoroughly the ...
(Date:6/16/2019)... ... June 14, 2019 , ... Emtec, ... will deliver a joint presentation with Versiti’s CIO at the Healthcare Industry ... Rosen Shingle Creek Resort. , Versiti Vice President and Chief Information Officer, Lynne ...
(Date:6/11/2019)... ... June 12, 2019 , ... ... discovery services, Abveris plans to leverage the Geneious Biologics platform as a premium ... Chief Technology Officer at Abveris, says: “The Geneious team has done an excellent ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... ... July 08, 2019 , ... Today, at the BIO World Congress ... Growers Association (NCGA) announced the winners of the Consider Corn Challenge II. Three ... using field corn to produce biobased materials. , “Corn is a sustainable, abundant ...
(Date:6/18/2019)... (PRWEB) , ... June 18, 2019 , ... Personalized ... Investigational New Drug (IND) application to the FDA for use of a person’s own ... as a treatment of osteoarthritis in the knee. This IND is the first ...
(Date:6/11/2019)... Va. (PRWEB) , ... June 11, 2019 , ... ... microlearning engagement, and Carilion Clinic, a national leader in opioid treatment, announced today ... virtual care. , Mytonomy recently deployed its virtual care platform at ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... providing proprietary interest to our methodology, processes, and diagnostic techniques. The patent ... extends Somnology’s IP rights including our proprietary sleep scoring methodology. The approval ...
Breaking Biology Technology:
Cached News: